Proposed code: PYC
Issue price: $0.20
Principal activities: Biopharmaceuticals Company.
Corporate: Joachim (Aki) von Roy (non-executive chairman); Stewart Washer (chief executive); Paul Watt (executive director); Harry Karelis (non-executive director); Bruce Fielding (non-executive director); Saliba Sassine (non-executive director).
www.phylogica.com.au
(08) 9227 8288
Phylogica aims to raise $5 million in order to enter into partnerships with larger biopharmaceutical companies.
Lead manager: Azure Capital